Invitrogen™ Dengue Virus Type 2/4 Capsid (Thailand/16681/1984) Recombinant Rabbit Monoclonal Antibody (HL2791)

Description

Dengue Virus Type 2/4 Capsid (Thailand/16681/1984) Recombinant Monoclonal Antibody for Western Blot, ICC/IF

The Dengue Virus Type 2/4 Capsid (Thailand/16681/1984) refers to the capsid protein of the Dengue virus serotypes 2 and 4, specifically from the strain isolated in Thailand in 1984. The capsid protein is a crucial component of the dengue virus, playing an essential role in the formation and stability of the viral particle. It encapsulates the viral RNA genome, protecting it from degradation and aiding in the assembly of new virions. Dengue virus, transmitted primarily by Aedes mosquitoes, is responsible for dengue fever, a significant global health concern characterized by high fever, severe headache, pain behind the eyes, joint and muscle pain, rash, and bleeding. Understanding the structure and function of the capsid protein is vital for developing vaccines and antiviral treatments. The Thailand/16681/1984 strain is often used in research to study the molecular biology and pathogenesis of dengue virus, as well as in the development of diagnostic tools, vaccines, and therapeutic agents aimed at controlling and preventing dengue infections.